Find a Clinical Trial
Thymomas
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Prostate Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052
- Details
ClinicalTrials.gov ID:
NCT02952534
Diagnosis Type:
NA
USOR Number:
16237
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Head and Neck Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Thyroid Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Prostate Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)
- Details
ClinicalTrials.gov ID:
NCT02975934
Diagnosis Type:
NA
USOR Number:
16238
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Mesothelioma
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Uterine Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Lymphomas
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-Label, Multicenter, Phase 1/2 Study of Tazemetostat (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Advanced Solid Tumors or With B Cell Lymphomas and Tazemetostat in Combination With Prednisolone in Subjects With Diffuse Large B Cell Lymphoma - E7438-G000-101
- Details
ClinicalTrials.gov ID:
NCT01897571
Diagnosis Type:
Non-Hodgkins
USOR Number:
16248
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Neuroendocrine Tumors
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Vaginal Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Biliary Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
An Open-label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies (CA209627)
- Details
ClinicalTrials.gov ID:
NCT02832167
Diagnosis Type:
NA
USOR Number:
16041
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Lymphomas
Clinical Trial at: Florida Cancer Affiliates - Ocala
A PHASE 1B, MULTI-CENTER, OPEN-LABEL STUDY OF NOVEL COMBINATIONS OF CC-122, CC-223, CC-292, AND RITUXIMAB IN DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA (CC-122-DLBCL-001)
- Details
ClinicalTrials.gov ID:
NCT02031419
Diagnosis Type:
NA
USOR Number:
13092
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Bladder Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
A Phase 2, Open-label, Single Agent, Multi-Center Study to Evaluate the Efficacy and Safety of a Pan-FGFR Tyrosine Kinase Inhibitor INCB054828 in Patients with Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations (INCB 54828-201)
- Details
ClinicalTrials.gov ID:
NCT02872714
Diagnosis Type:
NA
USOR Number:
15228
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Breast Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel plus Dexamethasone (SEVI-D) in Subjects with Advanced Breast Cancer (INO-VT-464-CL-006)
- Details
ClinicalTrials.gov ID:
NCT02580448
Diagnosis Type:
NA
USOR Number:
16010
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Breast Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma (HER2CLIMB) (ONT-380-206)
- Details
ClinicalTrials.gov ID:
NCT02614794
Diagnosis Type:
NA
USOR Number:
16195
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Leukemia
Clinical Trial at: Florida Cancer Affiliates - Ocala
(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with TGR-1202 for Patients Previously Enrolled in Protocol UTX-TGR-304
- Details
ClinicalTrials.gov ID:
NCT02656303
Diagnosis Type:
CLL
USOR Number:
16213
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Lymphomas
Clinical Trial at: Florida Cancer Affiliates - Ocala
SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above
- Details
ClinicalTrials.gov ID:
NCT01716806
Diagnosis Type:
Hodgkins
USOR Number:
11282
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
- Details
ClinicalTrials.gov ID:
NCT01374360
Diagnosis Type:
NA
USOR Number:
08160
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Mesothelioma
Clinical Trial at: Florida Cancer Affiliates - Ocala
Double blind, randomised, multicentre, phase II/III study of nintedanib in combination with pemetrexed/cisplatin followed by continuing nintedanib monotherapy versus placebo in combination with pemetrexed/cisplatin followed by continuing placebo monotherapy for the treatment of patients with unresectable malignant pleural mesothelioma (1199.93)
- Details
ClinicalTrials.gov ID:
NCT01907100
Diagnosis Type:
NA
USOR Number:
15175
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032
Lung Cancer
Clinical Trial at: Florida Cancer Affiliates - Ocala
A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects with Advanced or Metastatic Non-small Cell Lung Cancer who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks(CheckMate 384- CA209384)
- Details
ClinicalTrials.gov ID:
NCT02713867
Diagnosis Type:
NA
USOR Number:
15203
- Practice Details
3130 SW 32nd Street
Ocala, Florida 34471
110.44 mi. away
P: (352) 732-4032